Reply to Antinori and Bausch-Jurken.

Autor: d'Entremont-Harris M; Emerging and Re-Emerging Infections Team, Queen Elizabeth II Health Sciences Centre, Pharmacy Department, Nova Scotia Health., Ramsey TD; Emerging and Re-Emerging Infections Team, Queen Elizabeth II Health Sciences Centre, Pharmacy Department, Nova Scotia Health.; College of Pharmacy, Faculty of Health, Dalhousie University., Pelletier É; Emerging and Re-Emerging Infections Team, Queen Elizabeth II Health Sciences Centre, Pharmacy Department, Nova Scotia Health., Goodall B; Division of Infectious Diseases, Department of Medicine, Nova Scotia Health-Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada., Barrett L; Division of Infectious Diseases, Department of Medicine, Nova Scotia Health-Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada.
Jazyk: angličtina
Zdroj: The Journal of infectious diseases [J Infect Dis] 2024 Aug 16; Vol. 230 (2), pp. 524-526.
DOI: 10.1093/infdis/jiae128
Abstrakt: Competing Interests: Potential conflicts of interest. L. B. reports grants, contracts, honoraria, and consulting fees for HIV and hepatitis C content with AbbVie and Gilead and initial consultancy discussion on immunologic topics in long COVID with AbbVie. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Databáze: MEDLINE